Proxodolol hydrochloride/Pilocarpine Hydrochloride

盐酸普索洛尔/盐酸毛果芸香碱

Report date: 2022/01/19 18:02:07

Base Information

Drug NameProxodolol hydrochloride/Pilocarpine Hydrochloride
Drug Alias NameProxodolol hydrochloride and Pilocarpine Hydrochloride盐酸毛果芸香碱/普索洛尔Proxodolol•Pilocarpine Hydrochloride普索洛尔+盐酸毛果芸香碱普索洛尔-盐酸毛果芸香碱 +[15
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors antagonistsAlpha adrenergic receptor antagonistsMuscarinic acetylcholine receptor agonists
TargetsBeta adrenergic receptorsMuscarinic acetylcholine receptorAlpha adrenergic receptor
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsGlaucoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2006/05/01
Country/TerritoryRussian Federation
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMoscow Endocrine Plant
China Registration ClassN/A

Develop Information

Active CompaniesMoscow Endocrine Plant
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeS01EB51
Related LinksN/A